These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19406600)

  • 1. Tetanus-diptheria-acellular pertussis (Tdap): tap the resources of the emergency department to fight pertussis.
    Adalja AA
    J Emerg Med; 2011 May; 40(5):548-9. PubMed ID: 19406600
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007.
    Hanson MP; Kwan-Gett TS; Baer A; Rietberg K; Ohrt M; Duchin JS
    Arch Pediatr Adolesc Med; 2011 Jul; 165(7):647-52. PubMed ID: 21727277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(3):55-6. PubMed ID: 22278160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
    Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
    Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tdap vaccination strategies for health care personnel.
    Kusek L
    J Nurs Care Qual; 2011; 26(4):287-91. PubMed ID: 21885932
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of cocooning against pertussis in a high-risk population.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2011 Jan; 52(2):157-62. PubMed ID: 21288837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACIP expands Tdap recommendations. An update from the Michigan Department of Community Health.
    Michigan Department of Community Health
    Mich Med; 2011; 110(2):22-3. PubMed ID: 21510165
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-acquired pertussis among newborns--Texas, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(22):600-3. PubMed ID: 18528316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The present and future control of pertussis.
    Cherry JD
    Clin Infect Dis; 2010 Sep; 51(6):663-7. PubMed ID: 20704492
    [No Abstract]   [Full Text] [Related]  

  • 15. What's wrong with acellular pertussis vaccines?
    Wiedermann BL
    Clin Ther; 2013 Feb; 35(2):115-8. PubMed ID: 23375491
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2010 pertussis outbreak and updated Tdap recommendations.
    Bell GC; Foster SL
    J Am Pharm Assoc (2003); 2011; 51(1):118-20. PubMed ID: 21247837
    [No Abstract]   [Full Text] [Related]  

  • 19. Have you had your Tdap?
    Merchant VA
    J Mich Dent Assoc; 2012 Sep; 94(9):14-5. PubMed ID: 23029803
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.